After adoption of the GFD, 4 30% of patients with CD report persisting symptoms and are considered to be affected by non-responsive CD (NRCD).
We present a unique study in which adolescents with screening-detected CD report their HRQoL before and one year after diagnosis and treatment.
Patients with CD report the greatest limitation in the Bodily Pain domain, whereas patients with Parkinson's disease report the greatest impairments in the Role Physical domain and patients with multiple sclerosis report the greatest impairments in the Vitality domain.
Children with type 1 diabetes and CD report limited availability of gluten-free products at school and restaurants, with dietary arrangements outside of the home reported as the most common issues related to GFD adoption.
31 32 Similarly, adults with type 1 diabetes and CD report lower QOL scores compared with patients with type 1 diabetes alone, 33 and adult patients with CD who present with symptoms adherent with the GFD show significant improvements in health-related QOL, whereas asymptomatic screen-detected cases describe a decline in self-perceived health.
Asymptomatic patients with CD report better self-perceived health and less concern with their disease prior to dietary modification [ 24, 25], and over half of patients following a GFD for more than 5 years have reported QOL as excellent or very good [ 26].
The UTI rates per 1,000 CD reported in this study are higher than those reported by Cheatham who found 10.4 crude and 7.9 adjusted UTI/1,000 CD in the patient population that underwent IAP monitoring versus 6.5 in the control group.
This is also illustrated by the majority of cases of CD reported by EuroTravNet in 2008 that were imported from Bolivia to Spain.
One-hundred-fifty patients with CD reporting increased stool frequency, meteorism and/or abdominal pain were prospectively evaluated for SIBO with the Hydrogen Glucose Breath Test (HGBT).
On the basis of available information, several hypotheses can be formulated to explain the reduction of CD103 cells in active CD reported by us in 14 patients.
Kero et al, in a cohort study of 59,867 children, including 114 children with CD, reported an adjusted relative risk of asthma in children with CD of 7.26 (95% CI: 4.49 11.01).
